NYSEHealth CareMedical DevicesSnapshot 2026-07-31
Reading AVNS? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthManagement screens strong on capital allocation, earnings delivery, the balance sheet, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 22% growth a year, above the roughly 2% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 0% on a typical day and fell roughly 18% in its worst 12-month stretch.
View RiskAVNS must maintain strong growth to justify its current price. Revenue grew 8.8% year over year, and the last quarter beat expectations by 57%. It trades at 28× P/E, slightly above the 27× peer median. The market is pricing in more growth than we forecast, indicating expectations look full. If AVNS cuts guidance on the next call, that could negatively impact the stock. Peer multiples imply a price about 22% below where it trades. This read is provisional; the thesis is on watch due to management falling behind on commitments.
Trailing returns as of 2026-07-24. AVNS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 1 analyst currently covering AVNS (as of Jul 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care Supplies — fair value, gap to price, and forward P/E.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-24. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
